Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIAD: Comparing Two Durations of Antibiotic Treatment for Children Hospitalized With Common Infections
NCT07322146Phase 4Enrolling by invitation
- Sponsor
- University of California, San Francisco
- Start
- Feb 2026
- Primary completion
- Aug 2031
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in pneumonia, skin and soft tissue infection (SSTI) and urinary tract infection (UTI) (2 arms), sponsored by University of California, San Francisco. Primary endpoint: DOOR-RADAR composite outcome at 15 days. Started Feb 2026; status: enrolling by invitation.
02
Conditions
pneumoniaskin and soft tissue infection (SSTI)urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT07322146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07322146.